Hypertension Canada treatment guidelines accurate for high-risk patients
“On the other hand, there is also a strong argument for initiating treatment without waiting for HBPM. Although the diagnostic threshold for hypertension has been lowered to 130/80 mmHg, Hypertension Canada generally recommends pharmacologic treatment for patients with BP ≥140/90 mmHg, as well as for patients with systolic BP 130–139 mmHg who are at high cardiovascular risk, including those with established cardiovascular disease, diabetes, chronic kidney disease, a Framingham Risk Score ≥20%, or age ≥75 years.”
Summary
Hypertension Canada defines hypertension at a diagnostic threshold of 130/80 mmHg but advises starting medication for anyone with BP ≥ 140/90 mmHg. It also recommends pharmacologic treatment for patients with systolic BP 130–139 mmHg who have high cardiovascular risk, such as established CVD, diabetes, chronic kidney disease, a Framingham Risk Score ≥ 20 %, or age ≥ 75 years.
Sources 60 searched
- The Evolution of Hypertension Management in Canada: A Review of the Current Guidelines - PMC
Globally, hypertension is defined ... the target threshold for individuals with diabetes to be ≤130/80 mmHg, and a threshold of <140/90 mmHg remains acceptable for lower-risk individuals [3]. These target goals have failed to be adequately reached globally....
- Hypertension Canada guideline for the diagnosis and treatment of hypertension in adults in primary care - PMC
Pharmacotherapy initiation for hypertension is recommended for adults with BP ≥140/90 mmHg and for adults with systolic BP 130–139 mmHg at high cardiovascular disease risk (strong recommendation, high-certainty evidence).
- Hypertension Canada guideline for the diagnosis and treatment of hypertension in adults in primary care - PMC
Pharmacotherapy initiation for hypertension is recommended for adults with BP ≥ 140/90 mm Hg and for adults with systolic BP 130–139 mm Hg at high cardiovascular disease risk (strong recommendation, high-certainty evidence).
- Epidemiologic Implications of the 2025 Hypertension Canada Guideline on Hypertension Prevalence, Treatment, and Control: A Population-based Cohort Study - ScienceDirect
Treatment initiation thresholds ... cardiovascular risk, BP ≥ 130/80 mm Hg for those with diabetes, SBP ≥ 130 mm Hg for those at high cardiovascular risk, and BP ≥ 140/90 mm Hg for all others....
- Hypertension Canada’s 2020 Evidence Review and Guidelines for the Management of Resistant Hypertension - ScienceDirect
Hypertension Canada also recommends a SBP target of <120 mm Hg, consistent with the present guideline.19 There is limited evidence on the use of specific antihypertensive agents to treat high BP in CKD.
- Hypertension Canada's 2020 Comprehensive Guidelines ...
Checking your browser before accessing pubmed.ncbi.nlm.nih.gov · Click here if you are not automatically redirected after 5 seconds
- Hypertension Guidelines in the United States and Canada
Hypertension Canada continues to recommend a BP target · of <140/90 mm Hg in most individuals and lower targets for
- Hypertension Guidelines in the United States and Canada: Are We Getting Closer? | Hypertension
The ACC/AHA guidelines recommend a uniform BP treatment target of <130/80 mm Hg for all subjects regardless of cardiovascular risk (Table).1 However, Hypertension Canada continues to recommend a BP target of <140/90 mm Hg in most individuals and ...
This fact check is free and donation-based. $1 powers ~30 fact-checks.
